Standards; Chiral Molecules; Enzyme Activators and Inhibitors;
应用:
The UDP-glucuronosyltransferases are phase II metabolic enzymes involved with detoxification processes (ie. drug metabolism) in the human body. In particular, UGT2B7 is responsible for the glucuronidation of approximately 40% of drugs that are metabolized by UGT enzymes.β-Phenyllongifolol is an inhibitor ofUGT2B7. Compounds that inhibit metabolic enzymes may provide insights for pharmacokinetic research in drug development.